4 Recruiting Metastatic Colorectal Cancer Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for metastatic colorectal cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Metastatic Colorectal Cancer studiesPhase 1 / Phase 2 Studies for Metastatic Colorectal Cancer
🟢 Recruiting Phase1 / Phase2
A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
📍 Yale University — New Haven, Connecticut
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases
📍 Icahn School of Medicine at Mount Sinai — New York, New York
View Study & Checklist ➔